Chunxia Liu Selected Research

Rhabdomyosarcoma

11/2021	Bioinformatics prediction and experimental verification identify MAD2L1 and CCNB2 as diagnostic biomarkers of rhabdomyosarcoma.
2/2019	GEFT aberrant expression in soft tissue sarcomas.
1/2019	MicroRNA-874 functions as a tumor suppressor in rhabdomyosarcoma by directly targeting GEFT.
7/2018	Safety markers for rhabdomyosarcoma cells using an in vivo imaging system.
1/2014	Overexpression of GEFT, a Rho family guanine nucleotide exchange factor, predicts poor prognosis in patients with rhabdomyosarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chunxia Liu Research Topics

Disease

36	Neoplasms (Cancer) 01/2023 - 11/2012
7	Carcinogenesis 10/2023 - 06/2013
6	Body Weight (Weight, Body) 10/2023 - 01/2018
5	Breast Neoplasms (Breast Cancer) 04/2022 - 05/2016
5	Rhabdomyosarcoma 11/2021 - 01/2014
5	Sarcoma (Soft Tissue Sarcoma) 11/2021 - 01/2015
5	Neoplasm Metastasis (Metastasis) 11/2020 - 01/2018
4	Hypoxia (Hypoxemia) 10/2023 - 06/2019
4	Type 2 Diabetes Mellitus (MODY) 01/2021 - 09/2017
4	Esophageal Squamous Cell Carcinoma 11/2020 - 11/2012
4	Hypoglycemia (Reactive Hypoglycemia) 10/2019 - 09/2017
3	Ischemia 01/2022 - 01/2020
3	Reperfusion Injury 01/2022 - 01/2020
3	Lung Injury 01/2022 - 01/2020
3	Obesity 01/2021 - 05/2018
3	Carcinoma (Carcinomatosis) 05/2018 - 06/2013
2	Inflammation (Inflammations) 04/2024 - 01/2022
2	Fibrosis (Cirrhosis) 01/2023 - 01/2023
2	Myocardial Infarction 01/2023 - 12/2022
2	Pain (Aches) 01/2023 - 01/2018
2	Stroke (Strokes) 10/2022 - 01/2022
2	Coronary Disease (Coronary Heart Disease) 01/2022 - 07/2016
2	Atherosclerosis 01/2021 - 05/2018
2	Metabolic Diseases (Metabolic Disease) 01/2021 - 05/2018
2	Liposarcoma 01/2020 - 01/2019
2	Liver Neoplasms (Liver Cancer) 06/2019 - 05/2018
2	Infections 01/2019 - 11/2012
2	Esophageal Neoplasms (Esophageal Cancer) 01/2019 - 07/2015
2	Leukemia 01/2018 - 01/2018
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2016 - 01/2016
2	Papillomavirus Infections 06/2013 - 11/2012
1	Neuroinflammatory Diseases 04/2024
1	Parkinson Disease (Parkinson's Disease) 04/2024
1	Squamous Cell Carcinoma of Head and Neck 12/2023
1	Pulmonary Arterial Hypertension 12/2023
1	Congenital Abnormalities (Deformity) 12/2023
1	Chromosome Aberrations (Chromosome Abnormalities) 10/2023
1	Infarction (Infarctions) 01/2023
1	Neuralgia (Stump Neuralgia) 01/2023
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2014
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2013
8	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 09/2017
5	Peptides (Polypeptides)IBA 10/2020 - 01/2019
4	Messenger RNA (mRNA)IBA 02/2021 - 01/2019
4	MicroRNAs (MicroRNA)IBA 01/2020 - 06/2015
3	LipidsIBA 04/2024 - 10/2019
3	Hematoxylin (Haematoxylon)IBA 08/2021 - 07/2018
3	Eosine Yellowish-(YS) (Eosin)IBA 08/2021 - 07/2018
3	ParaffinIBA 01/2020 - 01/2014
2	AcidsIBA 04/2024 - 01/2018
2	HydrogelsIBA 01/2023 - 01/2020
2	Proteolysis Targeting ChimeraIBA 01/2023 - 02/2020
2	snake venom protein C activatorIBA 01/2023 - 02/2020
2	mouse MIRN29 microRNAIBA 01/2023 - 01/2020
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 01/2020
2	Protein Kinases (Protein Kinase)IBA 11/2020 - 02/2018
2	PerilipinsIBA 01/2020 - 05/2018
2	RNA (Ribonucleic Acid)IBA 01/2020 - 06/2019
2	Nonesterified Fatty Acids (NEFA)IBA 01/2020 - 09/2017
2	Antineoplastic Agents (Antineoplastics)IBA 06/2019 - 01/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 06/2019 - 02/2018
2	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 02/2019 - 01/2014
2	3-hydroxy-5-estrane-17-carbonitrile (ACN)IBA 01/2019 - 10/2014
2	Arsenic Trioxide (Trisenox)FDA Link 01/2018 - 01/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2016 - 05/2016
2	Formaldehyde (Formol)FDA Link 01/2015 - 01/2014
2	VimentinIBA 01/2015 - 01/2014
2	EpitopesIBA 10/2014 - 11/2012
2	HLA-DQB1 antigen (HLA DQB1)IBA 10/2014 - 11/2012
2	HLA-DRB1 Chains (HLA DRB1)IBA 10/2014 - 11/2012
1	N-acylethanolaminesIBA 04/2024
1	amidaseIBA 04/2024
1	Cyclin D1IBA 12/2023
1	Histidine (L-Histidine)FDA Link 10/2023
1	Long Noncoding RNAIBA 10/2023
1	AnthraquinonesIBA 10/2023
1	Histones (Histone)IBA 10/2023
1	Decellularized Extracellular MatrixIBA 01/2023
1	Chemokine CXCL12IBA 01/2023
1	Blood Glucose (Blood Sugar)IBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	Nonsense Codon (Nonsense Mutation)IBA 01/2023
1	GelatinIBA 01/2023
1	NucleotidesIBA 01/2023
1	LigandsIBA 01/2023
1	Neuregulin-1 (Neuregulin 1)IBA 12/2022
1	SolutionsIBA 12/2022
1	FibrinIBA 12/2022
1	CholesterolIBA 10/2022
1	A-Form DNA (A-DNA)IBA 04/2022

Therapy/Procedure

10	Therapeutics 01/2023 - 05/2016
1	Traction 12/2023
1	Aftercare (After-Treatment) 12/2023
1	Thoracoplasty 12/2023
1	Injections 01/2023
1	Transplantation 01/2023
1	Urinary Diversion (Ileal Conduit) 01/2023
1	Cystectomy 01/2023
1	Lasers (Laser) 04/2022